tm
Seeing Is Believing
tm
Seeing Is Believing
Prometheus Biosciences's activity chart (see below) currently has 91 price targets and 67 ratings on display.
Analysts average stock forecasts to be materialized ratio is 86.53% with an average time for these price targets to be met of 259.59 days.
Most recent stock forecast was given by GREGORY RENZA from RBC on 10-May-2023. First documented stock forecast 22-Jun-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 10-May-2023
$200
$0.08 (0.04%)
$200
3 years 5 months 30 days ago
(10-May-2023)
5/7 (71.43%)
$5.84 (3.01%)
48
Buy Since 24-Feb-2023
$200
$0.08 (0.04%)
$160
3 years 5 months 30 days ago
(10-May-2023)
1/2 (50%)
$5.84 (3.01%)
52
Buy Since 10-Jun-2022
$138
$-61.92 (-30.97%)
$114
3 years 6 months 22 days ago
(18-Apr-2023)
3/4 (75%)
$-55.5 (-28.68%)
63
Buy Since 26-Apr-2021
$200
$0.08 (0.04%)
$139
3 years 6 months 22 days ago
(18-Apr-2023)
5/6 (83.33%)
$6.5 (3.36%)
115
Buy Since 12-Nov-2021
$200
$0.08 (0.04%)
3 years 6 months 23 days ago
(17-Apr-2023)
2/3 (66.67%)
$6.49 (3.35%)
73
What is RXDX (Prometheus Biosciences) average time for price targets to be met?
Which analyst most recently updated their price target on RXDX (Prometheus Biosciences)?
Which analyst has the most public recommendations on RXDX (Prometheus Biosciences)?
Which analyst is the currently most bullish on RXDX (Prometheus Biosciences)?
Which analyst is the currently most reserved on RXDX (Prometheus Biosciences)?
